XOMA (NASDAQ:XOMAP – Get Free Report) is projected to release its resultson Thursday, July 30th. Analysts expect the company to post earnings of $0.1761 per share and revenue of $13.91 million for the quarter.
XOMA Price Performance
XOMA stock opened at $24.98 on Thursday. XOMA has a 12 month low of $24.93 and a 12 month high of $30.00. The stock has a fifty day simple moving average of $25.30 and a two-hundred day simple moving average of $25.81.
XOMA Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, July 14th. Investors of record on Thursday, July 2nd were given a dividend of $0.5391 per share. The ex-dividend date of this dividend was Thursday, July 2nd. This represents a $2.16 annualized dividend and a dividend yield of 8.6%.
About XOMA
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Read More
- Five stocks we like better than XOMA
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
